阿扎那韦与质子泵抑制剂和H2受体阻滞剂的联合使用。 - Suppr

Suppr

超能文献

Co-administration of atazanavir with proton-pump inhibitors and H2 blockers.

作者信息

Khanlou Homayoun, Farthing Charles

出版信息

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):503. doi: 10.1097/01.qai.0000167477.20428.ce.

DOI:10.1097/01.qai.0000167477.20428.ce

PMID:16010179

Abstract

摘要

相似文献

Co-administration of atazanavir with proton-pump inhibitors and H2 blockers.阿扎那韦与质子泵抑制剂和H2受体阻滞剂的联合使用。

J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):503. doi: 10.1097/01.qai.0000167477.20428.ce.

Further information on the administration of h2-receptor antagonists with atazanavir.关于阿扎那韦与H2受体拮抗剂联合使用的更多信息。

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):516. doi: 10.1097/01.qai.0000221687.75434.b4.

Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?接受阿扎那韦治疗的患者使用质子泵抑制剂疗法：禁忌？

J Acquir Immune Defic Syndr. 2006 Mar;41(3):394-6. doi: 10.1097/01.qai.0000192002.23400.6e.

Lack of interaction between atazanavir and proton pump inhibitors in HIV-infected patients treated with ritonavir-boosted atazanavir.在接受利托那韦增强型阿扎那韦治疗的HIV感染患者中，阿扎那韦与质子泵抑制剂之间缺乏相互作用。

J Acquir Immune Defic Syndr. 2006 Mar;41(3):393-4; author reply 394. doi: 10.1097/01.qai.0000197075.56397.a5.

Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.抑酸剂对洛匹那韦/利托那韦及利托那韦增效阿扎那韦药代动力学的影响

J Clin Pharmacol. 2008 May;48(5):553-62. doi: 10.1177/0091270007313392.

Review of atazanavir: a novel HIV protease inhibitor.

Expert Opin Pharmacother. 2005 Aug;6(9):1565-72. doi: 10.1517/14656566.6.9.1565.

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.阿扎那韦的临床药代动力学及疗效与耐受性总结

Clin Pharmacokinet. 2005;44(10):1035-50. doi: 10.2165/00003088-200544100-00003.

Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.200毫克阿扎那韦对每日一次给予感染HIV患者的1600/100毫克沙奎那韦和利托那韦的细胞内及血浆药代动力学的影响。

J Antimicrob Chemother. 2006 Nov;58(5):1009-16. doi: 10.1093/jac/dkl379. Epub 2006 Sep 19.

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.孕烷X受体单核苷酸多态性（PXR 63396C→T）与未增强的阿扎那韦浓度降低之间的关联。

Clin Infect Dis. 2008 Nov 1;47(9):1222-5. doi: 10.1086/592304.

BMS-232632, a new protease inhibitor, is taken once daily.新型蛋白酶抑制剂BMS-232632，每日服用一次。

Posit Living. 2000 Jul;9(6):22.

引用本文的文献

Atazanavir-Concentrate Loaded Soft Gelatin Capsule for Enhanced Concentration in Plasma, Brain, Spleen, and Lymphatics.用于提高血浆、脑、脾脏和淋巴管中浓度的阿扎那韦浓缩软胶囊。

AAPS PharmSciTech. 2022 Sep 28;23(7):270. doi: 10.1208/s12249-022-02428-0.

Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus.奈非那韦-质子泵抑制剂药物相互作用对人类免疫缺陷病毒患者的临床意义。

Pharmacotherapy. 2011 Mar;31(3):253-61. doi: 10.1592/phco.31.3.253.

Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.单独使用及与利托那韦联合使用时奥美拉唑对茚地那韦血药浓度的影响。

Am J Health Syst Pharm. 2008 Mar 1;65(5):422-8. doi: 10.2146/ajhp070226.

Drug interactions between HIV protease inhibitors and acid-reducing agents.HIV蛋白酶抑制剂与抗酸剂之间的药物相互作用。

Clin Pharmacokinet. 2008;47(2):75-89. doi: 10.2165/00003088-200847020-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验